Recent announcements around the CMS 340B program have made oncology programs anxious about reimbursement costs. ECG’s Jessica Turgeon will moderate a panel addressing issues around cancer drug pricing and accessibility under the new rules.
ECG is proud to be a sponsor of the ACCC 44th Annual Meeting & Cancer Center Business Summit.
Jessica Turgon, MBA
ECG Management Consultants
Allen S. Lichter, MD, FASCO
Value in Cancer Care Consortium
Ira Klein, MD, MBA, FACP